Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers medicines and vaccines across several therapeutic areas, including cardiovascular, metabolic, and women's health treatments under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, along with oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. Pfizer also provides medicines and vaccines for pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and treatments for amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. The company is also involved in contract manufacturing and serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, and disease control and prevention centers. Pfizer has collaboration agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., Myovant Sciences Ltd., Akcea Therapeutics Inc., Merck KGaA, Valneva SE, BioNTech SE, and Arvinas Inc. Founded in 1849, the company is headquartered in New York, New York.
| Symbol | PFE |
|---|---|
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| CEO | Albert Bourla |
| Employees | 81000 |
| Headquarters | New York City, NY, US |
| IPO | 1972-06-01 |
| Website | www.pfizer.com |